2X0 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetCorteva’s low leverage and substantial equity base provide financial flexibility through agricultural cycles. This supports continued investment in products and technology, reduces balance-sheet strain, and gives management greater capacity to absorb volatility or fund strategic priorities.
New-product And Licensing PipelineA growing contribution from new crop-protection products can improve portfolio durability as older products mature and pricing becomes more competitive. Continued innovation also supports customer relevance, volume growth, and the potential for better mix over multiple seasons.
Operating Execution And GuidanceStrong first-half execution, productivity savings, margin expansion, and raised guidance indicate that Corteva is converting commercial activity into improved earnings. If sustained, these gains can strengthen operating leverage and support earnings growth beyond a single reporting period.
Bears Say
Weak Recent Revenue TrajectoryThe sharp TTM revenue decline shows that Corteva’s broad scale has not recently translated into consistent top-line growth. Persistent weakness would limit operating leverage, make margin improvement harder to sustain, and increase reliance on productivity actions or favorable product mix.
Volatile Cash GenerationThe material drop in operating and free cash flow reduces near-term funding capacity for investment, shareholder returns, and strategic actions. Although TTM free cash flow still covered a meaningful share of earnings, the volatility signals less dependable cash conversion across business cycles.
Crop-protection Pricing And Brazil PressureSustained pricing pressure in crop protection can offset volume gains and new-product benefits, limiting revenue quality and margin expansion. Brazil adds a specific regional challenge because management expects no price recovery in 2026 and faces generics-driven competition in some categories.
Corteva News
2X0 FAQ
What was Corteva’s price range in the past 12 months?
Currently, no data Available
What is Corteva’s market cap?
Corteva’s market cap is CHF43.08B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is Nov 11, 2026 which is in 40 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on Jul 30, 2026. The company reported CHF0.287 earnings per share for the quarter, beating the consensus estimate of CHF0.279 by CHF0.008.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva does not currently pay dividends.
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is -0.05.
How many shares outstanding does Corteva have?
Corteva has 667,196,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of CHF0.287 in its last earnings report, beating expectations of CHF0.279. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in CH:2X0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF69.13 (― Upside)
CHF69.13 (― Upside)
Blogger Sentiment
Bullish
CH:2X0 Sentiment 82%
Sector Average 68%
Sector Average 68%
News Sentiment
Bullish
Bullish news 70%
Bearish news 30%
Bearish news 30%
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.58%
12-Months-Change
Fundamentals
Return on Equity
1.10%
Trailing 12-Months
Asset Growth
-0.28%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
2X0 Company Deck
2X0 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.View all CH:2X0 earnings summaries2X0 Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
